Food Standards Agency
Insufficient evidence for vitamin D preventing or treating acute respiratory tract infections
The Scientific Advisory Commission on Nutrition (SACN) and the National Institute for Health and Care Excellence (NICE) yesterday published their rapid reviews exploring the role of Vitamin D supplementation in reducing the risk of Acute Respiratory Tract Infections (ARTIs) and the prevention and treatment of COVID-19.
Vitamin D is needed to keep bones and muscles healthy. The current UK government advice is that everyone should take a daily 10 microgram vitamin D supplement to protect musculoskeletal health. It has also been suggested that vitamin D could reduce the risk of ARTIs and COVID-19.
Public Health England (PHE) commissioned SACN to examine new evidence on whether vitamin D supplementation could reduce the risk of ARTIs and supported NICE to review emerging evidence on vitamin D and the prevention and treatment of COVID-19.
SACN rapid review
SACN’s rapid review (Opens in a new window) assessed evidence on vitamin D and ARTIs that had been published since the last SACN review in 2016. ARTIs refers to any infection of the sinuses, throat, airways or lungs. The review did not look specifically at the effect of vitamin D supplementation on COVID-19 risk. The review concluded that evidence currently does not support vitamin D supplementation to prevent ARTIs in the general UK population. The review reiterates the importance of vitamin D for bone and muscle health.
Sunlight is the primary source of Vitamin D. That is why with ‘stay at home’ measures in place the UK Government re-issued advice (Opens in a new window) at the beginning of April 2020 that everyone takes a daily vitamin D supplement to mitigate the effects of reduced time outdoors.
NICE rapid evidence summary
PHE also supported NICE to conduct a rapid evidence summary (Opens in a new window) evaluating emerging evidence on vitamin D in relation to COVID-19. The review concluded that there is currently no evidence to support taking vitamin D supplements to reduce the risk or severity of COVID-19.
PHE, SACN and NICE are aware that a systematic review and controlled trials on vitamin D and COVID-19 are underway and will continue to monitor and assess new evidence as it is published.
Latest News from
Food Standards Agency
FSA Board meeting papers published for September 202004/09/2020 10:25:00
The agenda and papers for the September Board meeting have been published.
FSA Board commits to building on pandemic insight to anticipate future challenges in the food system28/08/2020 11:10:00
Horizon scanning was one of the main topics of discussion as the Food Standards Agency (FSA) Board met online this week.
Relaunch of independent science advisory committee websites25/08/2020 16:05:00
Today marks the relaunch of the Food Standards Agency’s (FSA) Scientific Advisory Committee (SAC) websites.
FSA Board meeting papers published for August 202014/08/2020 10:25:00
The agenda and papers for the August Board meeting have been published.
FSA launches campaign to help food sector adapt to the 'new normal'13/08/2020 14:10:00
The Here to Help campaign provides a practical guide for food businesses on how to register, re-open and adapt to the way they trade safely during the COVID-19 pandemic.
COVID-19 Consumer Tracker waves three and four report published12/08/2020 12:25:00
The Food Standards Agency (FSA) has today published the latest findings of the COVID-19 Consumer Tracker and additional qualitative research including social media listening.
FSA welcomes sentencing of DNP seller03/08/2020 14:10:00
The Food Standards Agency (FSA) welcomes the sentencing of a man who unlawfully sold DNP for human consumption.
Report into international foodborne disease rates published03/08/2020 09:15:00
The Food Standards Agency has published the first of three scientific reports, which attempt to compare international food standards.